Please wait a minute...
Journal of Neurorestoratology  2016, Vol. 4 Issue (1): 79-84    doi: 10.2147/JN.S119874
Mesenchymal stromal cell therapy in ischemic stroke
Ye Zhang, Hong Deng, Chao Pan, Yang Hu, Qian Wu, Na Liu, Zhouping Tang
Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China
Download: PDF (130 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Stroke is a clinical disease with high incidence, high disability rate, and high mortality. But effective and safe therapy for stroke remains limited. Adult mesenchymal stromal cells (MSCs) perform a variety of therapeutic functions. MSC delivery improves neurological outcomes in ischemic stroke models via neurorestorative and neuroprotective effects such as angiogenic effects, promoting endogenous proliferation, and reducing apoptosis and inflammation. MSC secretome also showed powerful therapeutic effects as a cell-based therapy in animal experiments. Several clinical trials on MSC implantation via different routes have now been completed in patients with stroke. Although challenges such as immunogenicity of allo-MSCs and large-scale production strategies need to be overcome, MSCs can be considered as a promising potential therapy for ischemic stroke.

Key wordsmesenchymal stromal cell      stroke      therapy      transplantation      exosomes     
Published: 26 December 2016
Corresponding Authors: Zhouping Tang, Department of Neurology, Tongji Hospital, to Tongji Medical College, Huazhong University of Science and Technology, Jiefang Blvd., No.1095, Wuhan 430030, People’s Republic of China,Tel +86 27 8366 3337,Fax +86 27 8366 2639,Email   
Cite this article:

Ye Zhang, Hong Deng, Chao Pan, Yang Hu, Qian Wu, Na Liu, Zhouping Tang. Mesenchymal stromal cell therapy in ischemic stroke. Journal of Neurorestoratology, 2016, 4: 79-84.

URL:     OR

1. Majid A.Neuroprotection in stroke: past, present, and future.ISRN Neurol. 2014;2014:515716.
2. Greco SJ, Corcoran KE, Cho KJ, Rameshwar P.Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells.Front Biosci. 2004;9:1782-1793.
3. Dominici M, Le Blanc K, Mueller I, et al.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.Cytotherapy. 2006;8(4):315-317.
4. Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges.Cell Stem Cell. 2015;17(1):11-22.
5. Aleynik A, Gernavage KM, Mourad Y, et al.Stem cell delivery of therapies for brain disorders.Clin Transl Med. 2014;3:24.
6. Liu L, Eckert MA, Riazifar H, Kang DK, Agalliu D, Zhao W.From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier?Stem Cells Int. 2013;2013:435093.
7. Zhao Y, Wang X, Dong P, et al.Bone marrow derived mesenchymal stem cells alleviated brain injury via down-regulation of interleukin-1beta in focal cerebral ischemic rats.Am J Transl Res. 2016;8(3):1541-1550.
8. Kim S, Chang KA, Kim J, et al.The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer’s disease mice.PLoS One. 2012;7(9):e45757.
9. Pirzad Jahromi G, Shabanzadeh Pirsaraei A, Sadr SS, et al.Multipotent bone marrow stromal cell therapy promotes endogenous cell proliferation following ischemic stroke.Clin Exp Pharmacol Physiol. 2015;42(11):1158-1167.
10. Li Y, Chen J, Chen XG, et al.Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery.Neurology. 2002;59(4):514-523.
11. Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD.Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.J Neurosci Res. 2006;84(7):1495-1504.
12. Chung TN, Kim JH, Choi BY, Chung SP, Kwon SW, Suh SW.Adipose-derived mesenchymal stem cells reduce neuronal death after transient global cerebral ischemia through prevention of blood-brain barrier disruption and endothelial damage.Stem cells Transl Med. 2015;4(2):178-185.
13. Moisan A, Favre I, Rome C, et al. Intravenous injection of clinical grade human MSCs after experimental stroke: functional benefit and microvascular effect. Cell Transplant. Epub2016 Feb 26.
14. Zhang LL, Zhang HT, Cai YQ, et al.Anti-inflammatory effect of mesenchymal stromal cell transplantation and quercetin treatment in a rat model of experimental cerebral ischemia.Cell Mol Neurobiol. 2016;36(7):1023-1034.
15. Lee SH, Jin KS, Bang OY, et al.Differential migration of mesenchymal stem cells to ischemic regions after middle cerebral artery occlusion in rats.PLoS One. 2015;10(8):e0134920.
16. Zhang L, Li Y, Zhang C, Chopp M, Gosiewska A, Hong K.Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia.Stroke. 2011;42(5):1437-1444.
17. Shin TH, Phukan G, Shim JS, et al.Restoration of polyamine metabolic patterns in in vivo and in vitro model of ischemic stroke following human mesenchymal stem cell treatment.Stem Cells Int. 2016;2016:4612531.
18. Cheng Q, Zhang Z, Zhang S, et al.Human umbilical cord mesenchymal stem cells protect against ischemic brain injury in mouse by regulating peripheral immunoinflammation.Brain Res. 2015;1594:293-304.
19. Tang G, Liu Y, Zhang Z, et al.Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia.Stem Cells. 2014;32(12):3150-3162.
20. Jeong CH, Kim SM, Lim JY, Ryu CH, Jun JA, Jeun SS.Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model.BioMed Res Int. 2014;2014:129145.
21. Yu X, Chen D, Zhang Y, et al.Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke.J Neurol Sci. 2012;316(1-2):141-149.
22. Lu H, Liu X, Zhang N, et al.Neuroprotective effects of brain-derived neurotrophic factor and noggin-modified bone mesenchymal stem cells in focal cerebral ischemia in rats.J Stroke Cerebrovasc Dis. 2016;25(2):410-418.
23. Wei N, Yu SP, Gu X, et al.Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.Cell Transplant. 2013;22(6):977-991.
24. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR.Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism.Am J Physiol Cell Physiol. 2008;294(3):C675-C682.
25. Lopatina T, Kalinina N, Karagyaur M, et al.Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo.PLoS One. 2011;6(3):e17899.
26. Zhao Q, Hu J, Xiang J, et al.Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke.Brain Res. 2015;1624:489-496.
27. Huang W, Lv B, Zeng H, et al.Paracrine factors secreted by MSCs promote astrocyte survival associated with GFAP downregulation after ischemic stroke via p38 MAPK and JNK.J Cell Physiol. 2015;230(10):2461-2475.
28. Tsai MJ, Tsai SK, Hu BR, et al.Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats.J Biomed Sci. 2014;21:5.
29. Webber J, Clayton A.How pure are your vesicles?J Extracell Vesicles. 2013;2:1-6.
30. Zhang Y, Chopp M, Meng Y, et al.Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury.J Neurosurg. 2015;122(4):856-867.
31. Yang T, Martin P, Fogarty B, et al.Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.Pharm Res. 2015;32(6):2003-2014.
32. Xin H, Li Y, Chopp M.Exosomes/miRNAs as mediating cell-based therapy of stroke.Front Cell Neurosci. 2014;8:377.
33. Jiang Y, Zhu W, Zhu J, Wu L, Xu G, Liu X.Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery.Cell Transplant. 2013;22(12):2291-2298.
34. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY; STARTING collaborators. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.Stem Cells. 2010;28(6):1099-1106.
35. Qiao LY, Huang FJ, Zhao M, et al.A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients.Cell Transplant. 2014;23(Suppl 1):S65-S72.
36. Honmou O, Houkin K, Matsunaga T, et al.Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.Brain. 2011;134(Pt 6):1790-1807.
37. Steinberg GK, Kondziolka D, Wechsler LR, et al.Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study.Stroke. 2016;47(7):1817-1824.
38. Zangi L, Margalit R, Reich-Zeliger S, et al.Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.Stem Cells. 2009;27(11):2865-2874.
39. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE.Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.Blood. 2006;108(6):2114-2120.
40. Grinnemo KH, Mansson A, Dellgren G, et al.Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium.J Thorac Cardiovasc Surg. 2004;127(5):1293-1300.
41. Lee KC, Lin HC, Huang YH, Hung SC.Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease.J Hepatol. 2015;63(6):1405-1412.
[1] Xiaoling Guo, Qun Xue, Jianhua Zhao, Yi Yang, Yang Yu, Dezhong Liu, Jing Liu, Wenwu Yang, Linsen Mu, Ping Zhang, Tianyi Wang, Hongyan Han, Shoufeng Liu, Yuhua Zhu, Tao Wang, Chuanqiang Qu, Chuanqiang Qu. Clinical diagnostic and therapeutic guidelines of stroke neurorestoration (2020 China version)[J]. Journal of Neurorestoratology, 2020, 8(4): 241-251.
[2] Shuanglin Xiang, Wenyong Gao, Haining Peng, Aibing Liu, Qiang Ao, Manjun Yang, Yanqiu Yu, Ying Liu, Raoxing Rong, Raoxing Rong. Standards of clinical-grade mesenchymal stromal cell preparation and quality control (2020 China Version)[J]. Journal of Neurorestoratology, 2020, 8(4): 197-216.
[3] Yunliang Wang, Xiaoling Guo, Jun Liu, Zuncheng Zheng, Ying Liu, Wenyong Gao, Juan Xiao, Yanqiu Liu, Yan Li, Manli Tang, Linlin Wang, Lin Chen, Di Chen, Deqiang Guo, Fei Liu, Weidong Chen, Baomin Chan, Bo Zhou, Aibing Liu, Gengsheng Mao, Hongyun Huang. Olfactory ensheathing cells in chronic ischemic stroke: A phase 2, double-blind, randomized, controlled trial[J]. Journal of Neurorestoratology, 2020, 8(3): 182-193.
[4] Xinyu Wang, Nan Sun, Xiangqi Meng, Meng Chen, Chuanlu Jiang, Jinquan Cai. Review of clinical nerve repair strategies for neurorestoration of central nervous system tumor damage[J]. Journal of Neurorestoratology, 2020, 8(3): 172-181.
[5] Chao Chen, Qingfa Chen, Yan Liu, Chongyang Zhang, Kaixiang Zhu, Xue Li, Haitao Xie, Rui Zhang. The cell repair research for Parkinson’s disease: A systematic review[J]. Journal of Neurorestoratology, 2020, 8(2): 93-103.
[6] Hongyun Huang, Lin Chen, Gengsheng Mao, Hari Shanker Sharma. Clinical neurorestorative cell therapies: Developmental process, current state and future prospective[J]. Journal of Neurorestoratology, 2020, 8(2): 61-82.
[7] Miaomiao Zhuang, Qingheng Wu, Feng Wan, Yong Hu. State-of-the-art non-invasive brain–computer interface for neural rehabilitation: A review[J]. Journal of Neurorestoratology, 2020, 8(1): 12-25.
[8] Zhu Zhang, Shiqing Zhang, Cathy Nga-Ping Lui, Peili Zhu, Zhang Zhang, Kaili Lin, Yiwu Dai, Ken Kin-Lam Yung. Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease[J]. Journal of Neurorestoratology, 2019, 7(4): 207-222.
[9] Weiwei Zhao,Chuanguang Ju,Daozhen Wang,Huifen Shen. Clinical observation of effects of ultrashort wave therapy combined with acupuncture and rehabilitation training in the treatment of patients with dysphagia after stroke[J]. Journal of Neurorestoratology, 2019, 7(3): 136-142.
[10] Wenbin Ding , Shaocheng Zhang, Dajiang Wu , Yanpeng Zhang , Hualong Ye. Hand function reconstruction in patients with chronic incomplete lower cervical spinal cord injury by nerve segment insert grafting: a preliminary clinical report[J]. Journal of Neurorestoratology, 2019, 7(3): 129-135.
[11] Zhenrong Zhang, Fangyong Wang, Mingjie Song. The cell repair research of spinal cord injury: a review of cell transplantation to treat spinal cord injury[J]. Journal of Neurorestoratology, 2019, 7(2): 55-62.
[12] Ekaterina Shevela, Marina Davydova, Natalia Starostina, Alexandra Yankovskaya, Alexandr Ostanin, Elena Chernykh. Intranasal delivery of M2 macrophage-derived soluble products reduces neuropsychological deficit in patients with cerebrovascular disease: a pilot study[J]. Journal of Neurorestoratology, 2019, 7(2): 89-100.
[13] Xiaoling Guo, Xin Wang, Yan Li, Bo Zhou, Weidong Chen, Lihua Ren. Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review[J]. Journal of Neurorestoratology, 2019, 7(2): 82-88.
[14] Shina Gu, Xiaodan Li, Lin Zhao, Huicong Ren, Chendi Pei, Wenqiang Li, Junlin Mu, Jinggui Song, Zhaohui Zhang. Decreased Npas4 expression in patients with post-stroke depression[J]. Journal of Neurorestoratology, 2019, 7(2): 101-108.
[15] Zikuan Leng, Nikhit Kethidi, Allen J. Chang, Lijun Sun, Jingjing Zhai, Yiting Yang, Jianzhong Xu, Xijing He. Muse cells and Neurorestoratology[J]. Journal of Neurorestoratology, 2019, 7(1): 18-25.